{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:03:02Z","timestamp":1761606182787,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jchromb.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T22:34:02Z","timestamp":1534804442000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of two LC-MS\/MS methods to assay urinary tylerdipine hydrochloride and its metabolites in healthy Chinese subjects"],"prefix":"10.1016","volume":"1096","author":[{"given":"Mingxue","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sufeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-1921","authenticated-orcid":false,"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiye","family":"Aa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.08.017_bb0005","first-page":"309","article-title":"Clinical use of azelnidipine in the treatment of hypertension in Chinese patients","volume":"11","author":"Chen","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40885-016-0042-0","article-title":"A review on prescribing patterns of antihypertensive drugs","volume":"22","author":"Jarari","year":"2015","journal-title":"Clin. Hypertens."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0015","first-page":"e28","article-title":"Heart disease and stroke statistics--2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0020","first-page":"67","article-title":"New generations of dihydropyridines for treatment of hypertension","volume":"14","author":"Wang","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mpmed.2015.12.029","article-title":"Calcium channel blockers","volume":"44","author":"Whyte","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3109\/00498254.2016.1156185","article-title":"Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses","volume":"46","author":"Wang","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0035","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.clinthera.2009.08.010","article-title":"Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers","volume":"31","author":"Makarounas-Kirchmann","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(98)00204-0","article-title":"Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect","volume":"349","author":"Masumiya","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1291\/hypres.30.797","article-title":"Renal-protective effect of T- and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study","volume":"30","author":"Ohishi","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(98)01018-X","article-title":"Effect of nilvadipine on the voltage-dependent Ca2+ channels in rat hippocampal CA1 pyramidal neurons","volume":"813","author":"Ishibashi","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/ajpregu.00276.2014","article-title":"Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system - news from the world of knock-out mice","volume":"308","author":"Hansen","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/bmc.2798","article-title":"Sensitive LC-MS\/MS-ESI method for simultaneous determination of nifedipine and atenolol in human plasma and its application to a human pharmacokinetic study","volume":"27","author":"Kallem","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4155\/bio.13.39","article-title":"Simultaneous estimation of amlodipine and atenolol in human plasma: a sensitive LC-MS\/MS method validation and its application to a clinical PK study","volume":"5","author":"Kallem","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0070","article-title":"Validated LC-MS\/MS method for the simultaneous determination of amlodipine and its major metabolites in human plasma of hypertensive patients","volume":"1","author":"Taguchi","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0075","first-page":"1","article-title":"Effects of CYP3A4*1G and CYP3A5*3 polymorphisms on pharmacokinetics of tylerdipine hydrochloride in healthy Chinese subjects","volume":"1","author":"Zhou","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4155\/bio.10.114","article-title":"Challenges in urine bioanalytical assays: overcoming nonspecific binding","volume":"2","author":"Ji","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2018.08.017_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpba.2016.08.003","article-title":"Optimization of solid-phase extraction and liquid chromatography-tandem mass spectrometry for simultaneous determination of capilliposide B and its active metabolite in rat urine and feces: overcoming nonspecific binding","volume":"131","author":"Cheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.08.017_bb0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jchromb.2009.02.069","article-title":"Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3\/NS4 protease inhibitor, in human plasma and human tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection","volume":"877","author":"Anderson","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217322134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217322134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:56:33Z","timestamp":1761605793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217322134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":18,"alternative-id":["S1570023217322134"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.08.017","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of two LC-MS\/MS methods to assay urinary tylerdipine hydrochloride and its metabolites in healthy Chinese subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}